# Dexmedetomidine for Prevention of Postoperative Delirium After Intracranial Operation for Brain Tumor

> **NCT04399343** · PHASE4 · UNKNOWN · sponsor: **Capital Medical University** · enrollment: 700 (estimated)

## Conditions studied

- Central Nervous System Diseases

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT04399343
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-01
- **Primary completion:** 2021-08-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2021-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04399343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04399343, "Dexmedetomidine for Prevention of Postoperative Delirium After Intracranial Operation for Brain Tumor". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04399343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*